Literature DB >> 23599607

Synovial sarcoma with isolated bone metastases, demonstrated by (99m)Tc-MDP bone scintigraphy and (18)F-FDG PET/CT.

Raja Senthil1, Raghava Kashyap, Anish Bhattacharya, Bhagwant Rai Mittal.   

Abstract

Entities:  

Year:  2012        PMID: 23599607      PMCID: PMC3628271          DOI: 10.4103/0972-3919.108896

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


× No keyword cloud information.
Sir, We describe a 25-year-old female patient, a known case of synovial sarcoma of lower end of left femur, who had undergone above knee amputation 5 years ago presented with low backache of 1-month duration. She was subjected to 99mTc -MDP bone scintigraphy to look for bone metastases. Whole-body bone scan in anterior projection [Figure 1a] and spot images in posterior view [Figures 1b–e] showed increased tracer uptake in multiple thoraco-lumbar vertebrae, right pubic bone, and right femoral head suggestive of widespread skeletal metastases. 18F-FDG PET/CT showed intense FDG uptake in the lytic lesions in multiple vertebrae, bilateral ribs, pelvis, and femora with soft tissue components along the pubic bones [Figures 2a–d]. CT scan showed multiple lytic lesions in the lower thoracic and lumbar vertebrae, right pubic bone, and right femoral head, consistent with metastases. However no FDG uptake or any nodules was seen in the lung parenchyma on either side [Figure 2e].
Figure 1

99mTc-MDP bone scintigraphy whole body in anterior projection (a) and spot images in posterior view (b-e), showing increased tracer uptake in multiple thoraco-lumbar vertebrae, right pubic bone, and right femoral head suggestive of widespread skeletal metastases

Figure 2

18F-FDG PET/CT showing intense FDG uptake in the lytic lesions in multiple vertebrae, bilateral ribs, pelvis, and femora with soft tissue components along the pubic bones (a-d). No FDG uptake or any nodules is seen in the lung parenchyma on either side (e)

99mTc-MDP bone scintigraphy whole body in anterior projection (a) and spot images in posterior view (b-e), showing increased tracer uptake in multiple thoraco-lumbar vertebrae, right pubic bone, and right femoral head suggestive of widespread skeletal metastases 18F-FDG PET/CT showing intense FDG uptake in the lytic lesions in multiple vertebrae, bilateral ribs, pelvis, and femora with soft tissue components along the pubic bones (a-d). No FDG uptake or any nodules is seen in the lung parenchyma on either side (e) Synovial sarcoma is the fourth most common type of soft-tissue sarcoma, accounting for 2.5-10.5% of all primary soft-tissue malignancies worldwide.[1-5] Metastatic disease occurs approximately in 50% of patients.[6] The most frequent metastatic site is the lung, affected in almost 94% of cases, followed by lymph nodes (4-18%). Even though bone metastases occur in 8-11% of patients, most of these patients also have lung metastases.[7-9] Isolated bone metastasis in the absence of lung involvement in synovial sarcoma is rare. Bone scintigraphy is a useful modality in the assessment of bone metastases in patients with synovial sarcoma. 18F-FDG PET/CT may be recommended as one stop shop investigation in the evaluation of these patients to detect bony as well as other organ involvement.
  9 in total

1.  SOFT TISSUE SARCOMA. A REVIEW OF 200 CASES.

Authors:  H F HARE; M J CERNY
Journal:  Cancer       Date:  1963-10       Impact factor: 6.860

2.  SYNOVIAL SARCOMA; AN ANALYSIS OF 34 TUMORS.

Authors:  N L CADMAN; E H SOULE; P J KELLY
Journal:  Cancer       Date:  1965-05       Impact factor: 6.860

3.  Synovial sarcoma prognostic factors and patterns of failure.

Authors:  Arnold C Paulino
Journal:  Am J Clin Oncol       Date:  2004-04       Impact factor: 2.339

4.  Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients.

Authors:  M Trassard; V Le Doussal; K Hacène; P Terrier; D Ranchère; L Guillou; M Fiche; F Collin; M O Vilain; G Bertrand; J Jacquemier; X Sastre-Garau; N B Bui; F Bonichon; J M Coindre
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

Review 5.  Soft tissue sarcomas involving the extremities and the limb girdles: a review.

Authors:  D E Thompson; H M Frost; J W Hendrick; R C Horn
Journal:  South Med J       Date:  1971-01       Impact factor: 0.954

6.  Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital.

Authors:  E L Spurrell; C Fisher; J M Thomas; I R Judson
Journal:  Ann Oncol       Date:  2005-01-14       Impact factor: 32.976

7.  The natural history of metastatic synovial sarcoma: experience of the Southwest Oncology group.

Authors:  J R Ryan; L H Baker; R S Benjamin
Journal:  Clin Orthop Relat Res       Date:  1982-04       Impact factor: 4.176

8.  Soft tissue sarcomas in Osaka, Japan (1962-1985): review of 290 cases.

Authors:  M Tsujimoto; K Aozasa; T Ueda; M Sakurai; S Ishiguro; A Kurata; K Ono; K Matsumoto
Journal:  Jpn J Clin Oncol       Date:  1988-09       Impact factor: 3.019

9.  Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.

Authors:  P Gustafson
Journal:  Acta Orthop Scand Suppl       Date:  1994-06
  9 in total
  1 in total

1.  Fluoro deoxyglucose positron emission tomography-computerized tomography in primary staging and response assessment of a rare case of primary pleural synovial sarcoma.

Authors:  Chidambaram Natrajan Balasubramanian Harisankar; Jijoe John; Kormath Veetil Gangadharan
Journal:  Indian J Nucl Med       Date:  2015 Jan-Mar
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.